Delivery Order SPE2DB22D2006-SPE2DB23FW1FU

Award Date 7/18/23
Potential Completion Date 8/8/23
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $13,971 delivery order to Amerisourcebergen Drug Corp for 200 unit vials of BOTOX. This firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, with performance taking place in Conshohocken, Pennsylvania from August 11th through September 1st, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the...
The Defense Logistics Agency awarded a $20,554.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 unit vials of BOTOX. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products to various Department of Defense entities. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding in mid-August. No subcontractors or set aside designations were indicated. The...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,644 to Amerisourcebergen Drug Corporation to supply 100 unit vials of BOTOX. The order is to be performed in Conshohocken, Pennsylvania from August 14 to September 5, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for BOTOX injections supports the DLA's mission to provide critical medical commodities to the armed forces....
The Defense Logistics Agency awarded a $69,855.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of BOTOX. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, with performance taking place in Conshohocken, Pennsylvania through September 1, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the U.S....
The Defense Logistics Agency awarded a $4,110.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 unit vials of BOTOX. Performance will take place in Conshohocken, Pennsylvania under the contract ending August 7, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the botulinum toxin to support DLA's mission of providing logistical support for all military services and several federal...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand three hundred thirty-two dollars and seventy cents ($12,332.70) to Amerisourcebergen Drug Corporation for one hundred (100) unit vials of BOTOX. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a three week period concluding on August 18, 2023. As the prime contractor, Amerisourcebergen Corporation will fulfill this requirement for the Defense...
The Defense Logistics Agency awarded a $6,985.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation under an existing contract vehicle. The order is to provide 200 unit vials of BOTOX for use by the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 18 and September 11, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency functions as...
The Defense Logistics Agency awarded a $36,092 delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of BOTOX. This firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of DLA and Department of Defense requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery by August 22nd. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $24,665 delivery order to Amerisourcebergen Drug Corporation for 100 unit vials of BOTOX. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support Defense Logistics Agency requirements. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the botulinum toxin under the terms of the order from July 27th through August 17th, 2023 to assist the Defense Logistics...
The Defense Logistics Agency awarded a $6,985.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of BOTOX. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, with performance taking place in Conshohocken, Pennsylvania from August 22nd to September 13th, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports all branches of the U.S....
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB23FW1FU
    Delivery Order

The Defense Logistics Agency awarded a $14,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit vials of BOTOX. The order is being fulfilled under the Prime Vendor Pharmaceutical program, which provides pharmaceuticals and medical/surgical supplies to DOD and other federal customers through a competitive multi-award contract vehicle. Amerisourcebergen will deliver the BOTOX vials to a customer located in Conshohocken, Pennsylvania by August 8, 2023 to support DOD medical treatment programs. No subcontractors or set aside designations were identified for this order.

Generated 12/23/23, 12:52 PM